<code id='64EF0AE244'></code><style id='64EF0AE244'></style>
    • <acronym id='64EF0AE244'></acronym>
      <center id='64EF0AE244'><center id='64EF0AE244'><tfoot id='64EF0AE244'></tfoot></center><abbr id='64EF0AE244'><dir id='64EF0AE244'><tfoot id='64EF0AE244'></tfoot><noframes id='64EF0AE244'>

    • <optgroup id='64EF0AE244'><strike id='64EF0AE244'><sup id='64EF0AE244'></sup></strike><code id='64EF0AE244'></code></optgroup>
        1. <b id='64EF0AE244'><label id='64EF0AE244'><select id='64EF0AE244'><dt id='64EF0AE244'><span id='64EF0AE244'></span></dt></select></label></b><u id='64EF0AE244'></u>
          <i id='64EF0AE244'><strike id='64EF0AE244'><tt id='64EF0AE244'><pre id='64EF0AE244'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:27616

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          comprehensive

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          European regulators consider appeal over Amylyx ALS drug
          European regulators consider appeal over Amylyx ALS drug

          PauloAmorim/VWPicsviaAPImagesLONDON—Thisweek,EuropeanregulatorsareconsideringanappealfromAmylyxPharm

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Life sciences deals on track to hit lowest point since 2017

          AdobeIt’snosecretthatbiotechindustryfundinghasfallenfromitsCovidhighs.Butwithjustafewmonthsleftinthe